Business
Medincell to Participate in the UBS Global Healthcare Conference (Palm Beach) and the Stifel Healthcare Conference (New-York)
MONTPELLIER, France, November 06, 2025--Regulatory News: Dr Grace Kim, Chief Strategy Officer, U.S. Finance, and Dr Richard Malamut, Chief Medical Officer, will speak on Medincell’s (Paris:MEDCL) value proposition, including recent developments and meet with investors at two upcoming investor conferences as follows:
About this update from Medincell Sa
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1772,"height":295,"url":"https://media.zenfs.com/en/business-wire.com/da016a9a98f42e9ace984836c80357aa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TCRD3Atk2EKBof5uyq05Qw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/da016a9a98f42e9ace984836c80357aa","width":960,"height":160},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/.yQdZM.cn7VwE7RvMwjBGQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/da016a9a98f42e9ace984836c80357aa","width":1200,"height":200}},"lazy":false},{"type":"text","content":"MONTPELLIER, France, November 06, 2025--(BUSINESS WIRE)--Regulatory News:","length":73,"tagName":"p"},{"type":"text","content":"Dr Grace Kim, Chief Strategy Officer, U.S. Finance, and Dr Richard Malamut, Chief Medical Officer, will speak on Medincell’s (Paris:MEDCL) value proposition, including recent developments and meet with investors at two upcoming investor conferences as follows:","length":260,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"2025 UBS Global Healthcare Conference - 10-13 November 2025, Palm Beach","length":71,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":71,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Stifel 2025 Healthcare Conference - 11-13 November 2025, New-York","length":65,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":65,"olType":false},{"type":"text","content":"Meetings may be requested via direct contact with Medincell or via banking representatives.","length":91,"tagName":"p"},{"type":"text","content":"About Medincell","length":15,"tagName":"p"},{"type":"text","content":"Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable treatments across multiple therapeutic areas. Our innovative treatments are designed to ensure adherence to medical prescriptions, enhance the effectiveness and accessibility of medicines, and reduce their environmental impact.These treatments combine active pharmaceutical ingredients with our proprietary BEPO® technology, which enables controlled drug delivery at therapeutic lev...